|
"tsou hh"的相關文件
顯示項目 51-60 / 116 (共12頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2017-02 |
Integrated care for geriatric frailty and sarcopenia: A randomized control trial
|
Chan, DCD;Tsou, HH;Chang, CB;Yang, RS;Tsauo, JY;Chen, CY;Hsiao, CF;Hsu, YT;Chen, CH;Chang, SF;Hsiung, CA;Kuo, KN |
| 國家衛生研究院 |
2017-02 |
A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, JS;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2017 |
Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C;Group, Taiwan Cooperative Oncology |
| 國家衛生研究院 |
2016-11-11 |
Assessing benefit and consistency of treatment effect under a discrete random effects model in multiregional clinical trials
|
Liu, JT;Chen, CT;Lan, KKG;Tzeng, CS;Hsiao, CF;Tsou, HH |
| 國家衛生研究院 |
2016-07 |
Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA
|
Wang, WY;Lin, TY;Twu, CW;Tsou, HH;Lin, PJ;Liu, YC;Huang, JW;Hsieh, HY;Lin, JC |
| 國家衛生研究院 |
2016-07 |
GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer
|
Hsu, CP;Chuang, HC;Lee, MC;Tsou, HH;Lee, LW;Li, JP;Tan, TH |
| 國家衛生研究院 |
2016-06 |
Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials
|
Liu, JT;Tsou, HH;Gordon Lan, KK;Chen, CT;Lai, YH;Chang, WJ;Tzeng, CS;Hsiao, CF |
| 國家衛生研究院 |
2016-05-03 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Shen, YY;Chao, Y;Chen, MH;Yeh, TS;Shan, YS;Huang, SF;Chen, LT |
| 國家衛生研究院 |
2016-04-21 |
The discrete random-effects model-assessing benefit and consistency of treatment effect
|
Tsou, HH;Lan, KKG;Liu, JT;Hsiao, CF |
| 國家衛生研究院 |
2015-09-01 |
Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients
|
Liu, SW;Liu, YL;Hwang, LL;Wang, SC;Kuo, HW;Wu, SL;Dai, YWE;Liu, SC;Ho, IK;Chen, ACH;Hsiao, CF;Tsou, HH |
顯示項目 51-60 / 116 (共12頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
